康泰生物2025年净利同比预降63.8%—75.7%

Core Viewpoint - Kangtai Biological (300601) forecasts a significant decline in net profit for 2025, estimating a range of 49 million to 73 million yuan, representing a decrease of 63.8% to 75.7% compared to the previous year [1] Group 1 - The decline in net profit is attributed to several factors, including adjustments in the immunization schedule for the quadrivalent vaccine, rising operating costs, and increased research and development expenditures [1]